financial post
Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Financial Post • 1 MONTH AGO
Ronald P. Mathison and MATCO Investments Ltd. File Early Warning Report Regarding Calfrac Well Services Ltd.
Financial Post • 1 MONTH AGO
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
Financial Post • 1 MONTH AGO
ZenaTech Closes Acquisition of Vara 3D, a Utah-Based Surveying and Mapping Firm Expanding Drone-as-a-Service to the High-Growth Solar Infrastructure Market
Financial Post • 1 MONTH AGO
MBAK Energy Solutions, Inc. (OTC:MBAK) partners with Carbon Zero Mobility in Kenya and the University of Michigan on Charger Design
Financial Post • 1 MONTH AGO
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Financial Post • 1 MONTH AGO
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Financial Post • 1 MONTH AGO